Erratum to: Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
CNS Drugs
.
2017 Jun;31(6):511.
doi: 10.1007/s40263-017-0435-y.
Authors
Katelyn R Keyloun
1
,
Ryan N Hansen
2
,
Zsolt Hepp
3
,
Patrick Gillard
3
,
Michael E Thase
4
,
Emily Beth Devine
2
Affiliations
1
Global Health Outcomes Strategy and Research, Allergan, 2525 Dupont Drive (T2-2P), Irvine, CA, 92612-1599, USA. krkeyloun@gmail.com.
2
Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA.
3
Global Health Outcomes Strategy and Research, Allergan, 2525 Dupont Drive (T2-2P), Irvine, CA, 92612-1599, USA.
4
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
PMID:
28451963
PMCID:
PMC6828180
DOI:
10.1007/s40263-017-0435-y
No abstract available
Publication types
Published Erratum